| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.44▼ | 12.68▼ | 12.70▼ | 12.62▼ | 12.16▲ |
| MA10 | 12.56▼ | 12.69▼ | 12.58▼ | 12.50▼ | 12.25▲ |
| MA20 | 12.66▼ | 12.65▼ | 12.64▼ | 12.35▲ | 10.73▲ |
| MA50 | 12.65▼ | 12.57▼ | 12.54▼ | 12.29▲ | 7.96▲ |
| MA100 | 12.55▼ | 12.39▲ | 12.40▲ | 10.55▲ | 7.78▲ |
| MA200 | 12.41▲ | 12.26▲ | 12.33▲ | 8.33▲ | 8.41▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.045▼ | -0.024▼ | -0.014▼ | 0.009▲ | 0.012▲ |
| RSI | 42.005▼ | 45.213▼ | 47.233▼ | 51.446▲ | 64.942▲ |
| STOCH | 3.428▼ | 55.986 | 46.833 | 71.011 | 61.615 |
| WILL %R | -91.736▼ | -84.507▼ | -84.507▼ | -38.675 | -18.591▲ |
| CCI | -87.463 | -85.156 | -83.131 | 75.096 | 71.604 |
|
Friday, February 13, 2026 02:57 AM
Eli Lilly (LLY) stock is in focus as the company ramps up inventory for its weight loss pill orforglipron as its FDA approval nears in Q2 2026. Read more here.
|
|
Friday, February 13, 2026 01:36 AM
Eli Lilly and Company (NYSE: LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulatory filing on Thursday.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 12.75 | 13.2094 | 12.39 | 12.44 | 105,408 |
| 12/02/26 | 12.71 | 12.71 | 12.249 | 12.35 | 54,700 |
| 11/02/26 | 12.92 | 13.1397 | 12.2901 | 12.84 | 88,317 |
| 10/02/26 | 12.70 | 13.0889 | 12.6901 | 12.93 | 100,519 |
| 09/02/26 | 12.74 | 12.74 | 12.06 | 12.55 | 83,100 |
| 06/02/26 | 12.33 | 12.6999 | 12.1789 | 12.64 | 76,543 |
| 05/02/26 | 12.33 | 13.11 | 11.52 | 11.70 | 148,083 |
| 04/02/26 | 12.83 | 12.9339 | 12.11 | 12.44 | 107,826 |
| 03/02/26 | 12.69 | 13.025 | 12.195 | 12.60 | 136,533 |
| 02/02/26 | 11.62 | 12.61 | 11.62 | 12.53 | 197,872 |
|
|
||||
|
|
||||
|
|